EyePoint Pharmaceuticals
EYPT
#6027
Rank
C$1.44 B
Marketcap
C$17.20
Share price
5.75%
Change (1 day)
99.78%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -C$0.33 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are C$31.37 Million. a decrease over its 2024 earnings that were of -C$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.32 Billion63.24%
2024 -C$0.2 Billion104.29%
2023 -C$95.57 Million-29.88%
2022 -C$0.14 Billion87.2%
2021 -C$72.81 Million38.58%
2020 -C$52.54 Million-24.56%
2019 -C$69.64 Million
2017 -C$31.77 Million22.59%
2016 -C$25.91 Million-8.02%
2015 -C$28.17 Million-296.09%
2014 C$14.36 M-174.02%
2013 -C$19.41 Million37.42%
2012 -C$14.13 Million-56.29%
2011 -C$32.31 Million-1062.38%
2010 C$3.35 M-250.43%
2009 -C$2.24 Million-89.5%
2008 -C$21.26 Million
2005 -C$13.11 Million56.99%
2004 -C$8.36 Million73.7%
2003 -C$4.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$2.98 Million-99.07% Bahamas
NRC Health
NRC
C$37.93 M-111.90%๐Ÿ‡บ๐Ÿ‡ธ USA